BBS9 and Bardet-Biedl syndrome: The bbs9-spMO morphant phenotype observed with p53-atgMO co-injection is reminiscent of what has been reported for BBS patients with clinical manifestations in multiple organs - including eye and brain (see MIM ID #209900).